Background {#Sec1}
==========

Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is an autosomal dominant inherited neurodegenerative disorder with a wide range of clinical manifestations \[[@CR1]\]. SCA3/MJD is caused by an unstable CAG trinucleotide repeat expansion within the coding region of a gene located on chromosome 14q32.1 \[[@CR2]\]. The predominant symptoms are progressive ataxia, ophthalmoplegia, spastic gait and peripheral neuropathy \[[@CR1]--[@CR3]\]. Previous morphometric SCA3/MJD MRI analysis revealed significant atrophy of the cerebellar hemispheres, cerebellar vermis, pontine base, middle cerebellar peduncle, medulla oblongata, cervical spinal cord and enlargement of the fourth ventricle \[[@CR3]--[@CR9]\]. However, only few studies have analyzed the possible relationship between brain degeneration and the ataxia severity in this disease \[[@CR7]--[@CR9]\]. In those reports, researchers have used manually predefined anatomical landmarks to segment and calculate the total volume of different anatomical structures \[[@CR7]\], automated region segmentation to calculate cortical thickness and volume \[[@CR8]\] or atlas predefined regions to later group them into one single region \[[@CR9]\]. Those analyses led to broad correlations between volume of the cerebellum, brainstem and other cortical regions and the ataxia impairment.

However, a more accurate mapping of the disease-related degeneration and its association with the symptoms is key for the development of possible treatments/therapies for this specific type of patients. Here, we assessed the ataxia severity and gray matter degeneration in a cohort of SCA3/MJD patients by using the scale for the assessment and rating of ataxia (SARA) and whole brain voxel based-morphometry (VBM) to find voxel-wise associations between brain atrophy and motor impairment.

Methods {#Sec2}
=======

Participants {#Sec3}
------------

The patient group consisted of seventeen patients with a molecular diagnosis of SCA3/MJD (10 female; right-handed; mean age/SD, 40.1/11.9 years, for more detailed information look at Table [1](#Tab1){ref-type="table"}). Motor impairment was measured using SARA \[[@CR10]\], which has eight items, including tests of gait, stance, sitting, and speech, as well as a finger-chase test, finger-nose test, fast alternating movements, and heel-shin test. The control group consisted of 17 healthy volunteers that were age and gender matched. All participants gave written, informed consent before entering the study. The procedures carried out were in accordance with the ethical standards of the committees on human experimentation of the Universidad Nacional Autonoma de Mexico.Table 1Demographics of the patient groupIDGenderAgeAge at onsetSARAP01F493926P02M584719.5P03F452526P04M373212.5P05F35336.5P06F23206P07F423512P08F24209P09F18162.5P10F45398P11M434014.5P12M342918P13M594919.5P14M33289.5P15F403020P16M564614.5P17F46411.5

Image acquisition {#Sec4}
-----------------

All images were acquired using a 32-channel quadrature head coil in a 3.0-T Achieva MRI scanner (Phillips Medical Systems, Eindhoven, The Netherlands). Foam-rubber cushion was used for fixing the head of the subject in place, so as to minimize any head movements. The high-resolution anatomical acquisition consisted of a 3-D T1 Fast Field-Echo sequence, with TR/TE of 8/3.7 ms, FOV of 256 × 256 mm, flip angle 25° and an acquisition and reconstruction matrix of 256 × 256, resulting in an isometric resolution of 1 × 1 × 1 mm.

Voxel-based morphometry {#Sec5}
-----------------------

Gray matter volume (GMV) measurements were performed using voxel based morphometry (VBM) as implemented on FSL (FMRIB, Oxford, UK) following the standard procedure as previously reported \[[@CR11]\]. Using the FSL randomise tool, a two-sample t test was performed between the SCA3 group and controls. Significance was defined as *p \<* 0.05 after correcting for multiple comparisons using the randomized permutation method (TFCE). For the SCA3 group, whole-brain correlation maps were created by calculating the Pearson's partial correlation between the GMV and SARA scores including age in the analysis. Partial correlation maps were corrected for multiple comparisons by using false discovery rate (FDR) with a *p* value \< 0.05.

Results {#Sec6}
=======

VBM analysis revealed gray matter atrophy in SCA3 patients compared to the control group (Fig. [1a](#Fig1){ref-type="fig"}) involving bilateral cerebellum, vermis, brainstem and the occipital cortex (Table [2](#Tab2){ref-type="table"}). Four significant negative correlations were found between GMV and SARA scores in the SCA3 group (Fig. [1b](#Fig1){ref-type="fig"}) in regions of the cerebellum and the cingulate gyrus (Table [3](#Tab3){ref-type="table"}).Fig. 1Brain regions showing gray matter atrophy and SARA-GMV correlation. **a** Significant gray matter atrophy in patients compared with controls; **b** significant partial correlations between patients' GMV and SARA Table 2Brain regions showing significant gray matter degeneration in SCA3/MJD patientsAnatomical regionXYZClustertLeft posterior cerebellum Crus II−26−86−3626337.73Right posterior cerebellum Crus II20−88−3214197.31Right brainstem4−14−222246.59Vermis IX−2−54−341146.45Pons2−14−242196.19Right anterior cerebellum lobule V12−58−201605.1Left lingual gyrus BA17−12−100−41324.42Left anterior cerebellum lobule I-IV−8−46−222133.59Coordinates in MNI space in mm. BA = Brodmann Area Table 3Brain regions showing significant correlation between GMV and SARAAnatomical regionXYZClusterPCRight cerebellum declive lobule VI32−64−14191−0.825Left cerebellum culmen lobule VI−28−50−18180−0.816Left cerebellum tonsil lobule IX−8−58−38155−0.792Right paracentral lobule BA64−848132−0.779Coordinates in MNI space in mm. BA = Brodmann Area, PC = partial correlation

Discussion {#Sec7}
==========

In this study, we analyzed the relationship between gray matter loss and SARA scores in SCA3 patients. As expected, significant negative correlations between SARA scores and GMV were found in the cerebellum, but also in the cingulate cortex.

Previous reports have shown the close relationship between the extent of the brain atrophy, predominately in the cerebellum, and a variety of symptoms in different SCA subtypes \[[@CR7]--[@CR9], [@CR12], [@CR13]\]. Accordingly, our analysis showed a significant negative correlation between GMV and the SARA score in the bilateral lobule VI, extending to lobule V, which are involved in sensorimotor processing as suggested by deficits in stroke patients \[[@CR14], [@CR15]\]. Lobule IX, which its GMV also correlated with SARA, is not only considered essential for visual guidance of movement \[[@CR14]\], but its damage has been related to gait and balance impairment \[[@CR15]\].

The only extra-cerebellar region where the GMV correlated with SARA score was the dorsal anterior cingulate, known to be critically involved in motor functions \[[@CR16]\]. A previous report showed a significant degeneration in SCA3 in this area \[[@CR6]\], however, our analysis also showed a negative correlation between GMV and the ataxia score, corroborating the functional relevance of this deterioration as shown by patients with lesions in this area, whom often show deficits in spontaneous initiation of movement and speech, as well as inability to suppress externally triggered motor subroutines \[[@CR16]\].

Conclusions {#Sec8}
===========

In Conclusion, we report specific key areas where the GMV shows a close relationship with the ataxia impairment in SCA3. These findings add to previous reports \[[@CR7], [@CR9]\], while providing a more accurate localization of the SCA3/MJD ataxia-related areas.
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